Podcast

Destigmatizing Urology: Dr. Pettaway discusses penile cancer

Author(s):

Urology Times staff

“When you compound the patient delay and…the physician delay, then you really get a delay in diagnosis,” says Curtis A. Pettaway, MD.

In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Curtis A. Pettaway, MD. He discusses the stigmas related to penile cancer from both the patient and physician perspectives. In addition, he highlights major developments in the space that are helping to effectively treat and normalize this disease. Pettaway is a professor of urology at the University of Texas MD Anderson Cancer Center in Houston.

Related Videos
Daniel Carson, MD, MS, answers a question during a Zoom video interview
Dr. Neal E. Rowe in an interview with Urology Times
Related Content
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
September 24th 2024

The role of surgery continues to evolve in seminoma

Jiping Zeng, MD Timothy A. Masterson, MD Clint Cary, MD, MBA, MPH
"RPLND is an attractive option for those who prefer to avoid chemotherapy," write Jiping Zeng, MD; Timothy A. Masterson, MD; and Clint Cary, MD, MPH, MBA.
Key updates from the AUA/ASRM male infertility guideline amendment
September 23rd 2024

Key updates from the AUA/ASRM male infertility guideline amendment

Urology Times staff
In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.
GU cancer diagnoses may have adverse health impacts for patients’ family members
September 12th 2024

GU cancer diagnoses may have adverse health impacts for patients’ family members

Hannah Clarke
“As health care professionals, we should take a multidisciplinary approach to addressing the stress of a cancer diagnosis by helping mitigate financial toxicity, treatment burden, and emotional impact on both the patient and their family," says Mouneeb M. Choudry, MD.
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
July 24th 2024

Speaking of Urology: Dr. Winter on the use of vaginal estrogen

Urology Times staff
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
FDA marks cisplatin drug shortage as resolved
July 9th 2024

FDA marks cisplatin drug shortage as resolved

Hannah Clarke
The cisplatin drug shortage was first announced on February 10, 2023.
FDA accepts BLA for subcutaneous nivolumab in solid tumors
Published: May 7th 2024 | Updated: May 21st 2024

FDA accepts BLA for subcutaneous nivolumab in solid tumors

Hannah Clarke
The FDA is set to have a decision regarding the subcutaneous nivolumab formulation on or by December 29, 2024.
© 2024 MJH Life Sciences

All rights reserved.